MiR-20a-5p Alleviates Kidney Ischemia/reperfusion Injury by Targeting ACSL4-dependent Ferroptosis.

Lang Shi,Zhixia Song,Yuzhen Li,Jing Huang,Fan Zhao,Yanwen Luo,Juan Wang,Fangjing Deng,Halinuer Shadekejiang,Mingjiao Zhang,Shengyu Dong,Xiongfei Wu,Jiefu Zhu
DOI: https://doi.org/10.1016/j.ajt.2022.09.003
IF: 9.369
2023-01-01
American Journal of Transplantation
Abstract:Ischemia/reperfusion injury (IRI) is prone to occur after kidney transplantation, leading to delayed graft function (DGF). MicroRNAs play a crucial role in the pathogenesis of ischemia/reperfusion-induced acute kidney injury, and miR-20a-5p was found to be the most significantly upregulated gene in a DGF patient cohort. However, the roles of microRNAs in transplanted kidneys remain largely unknown. In this study, we found that miR-20a-5p was upregulated in the kidneys of acute kidney injury mice and in patients with DGF. We identified early growth response-1 as a critical upstream target and verified the binding of early growth response-1 to a predicted sequence in the promoter region of the miR-20a-5p gene. Functionally, the miR-20a-5p mimic attenuated IRI and postischemic renal fibrosis, whereas the miR-20a-5p inhibitor delivery aggravated IRI and fibrosis. Importantly, delivery of the miR-20a-5p mimic or inhibitor in the donor kidneys attenuated or aggravated renal loss and structural damage in cold storage transplantation injury. Furthermore, our study identified miR-20a-5p as a negative regulator of acyl-CoA synthetase long-chain family member 4 (ACSL4) by targeting the 3' untranslated region of ACSL4 mRNA, thereby inhibiting ACSL4-dependent ferroptosis. Our results suggest a potential therapeutic application of miR-20a-5p in kidney transplantation through the inhibition of ACSL4-dependent ferroptosis.
What problem does this paper attempt to address?